Abstract
Hepatitis C is a worldwide problem of public health and it is estimated that around 3% of world population is infected by Hepatitic C virus (HCV). Chronic infection can progress to hepatic cirrhosis and hepatocelular carcinoma and it is currently the major cause of liver transplantation. Current therapy based on pegylated interferon (PEF-IFN) and ribavirin presents low efficacy, severe si…